Literature DB >> 10030792

Low-dose intramuscular polymyxin B improves survival of septic rats.

T Mayumi1, J Takezawa, H Takahashi, N Kuwayama, T Fukuoka, K Shimizu, K Yamada, S Kondo, K Aono.   

Abstract

UNLABELLED: Polymyxin B (PLB) is a cationic antibiotic that also stoichiometrically neutralizes the lipid A moiety of endotoxin. We examined effects of a small dose of PLB on the mortality of rats with cecal ligation and puncture, on LPS-stimulated nitric oxide (NO) production, and on tumor necrosis factor alpha (TNF alpha) production by isolated rat Kupffer cells.
MATERIALS AND METHODS: In vivo studies: Cecal ligation and puncture (CLP) was performed under anesthesia in 28 rats. One hour after CLP, either 600 U/kg of PLB or saline was administered intramuscularly every 6 h (PLB group: n = 12; control group: n = 16). Plasma endotoxin was measured at 3 and 24 h after the CLP by the Endospecy test. This was compared with survival. IN VITRO STUDIES: Kupffer cells were isolated from the normal rat liver. The cells were incubated with LPS or LPS + PLB. After 24 h, NO and TNF alpha content were measured using the Griess and ELISA methods, respectively.
RESULTS: Low dose PLB significantly decreased the endotoxin levels at both 3 and 24 h (5.5 +/- 2.1 pg/mL vs. 32.8 +/- 3.6 at 3 h; 26.1 +/- 6.1 vs. 49.1 +/- 5.6 at 24 h (p < .05) after CLP. PLB significantly improved survival of CLP rats (68.8% in the control group vs. 100% in the PLB treated group on 3 days after CLP, p < .001). PLB also attenuated NO and TNF alpha production from the Kupffer cells.
CONCLUSION: Intramuscular PLB administered in low doses may improve the mortality of sepsis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10030792     DOI: 10.1097/00024382-199902000-00002

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

1.  Preparation of immunoglobulin Y (IgY) against lipopolysaccharide using gel chromatography from the yolks of eggs laid by immunized hens.

Authors:  Siyuan Ma; Yaping Zhang
Journal:  Protein J       Date:  2010-10       Impact factor: 2.371

2.  Structural correlation between lipophilicity and lipopolysaccharide-sequestering activity in spermine-sulfonamide analogs.

Authors:  Mark R Burns; Scott A Jenkins; Nicolas M Vermeulen; Rajalakshmi Balakrishna; Thuan B Nguyen; Matthew R Kimbrell; Sunil A David
Journal:  Bioorg Med Chem Lett       Date:  2006-09-28       Impact factor: 2.823

3.  Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice.

Authors:  Ling Guo; Zhong Zheng; Junting Ai; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

Review 4.  Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis?

Authors:  Corinna Lupp; Silke Baasner; Can Ince; Frank Nocken; John F Stover; Martin Westphal
Journal:  Crit Care       Date:  2013-05-29       Impact factor: 9.097

5.  Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues.

Authors:  Weibing Dong; Xiaoman Mao; Yue Guan; Yao Kang; Dejing Shang
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.